SARS-CoV-2 RT-qPCR Ct values in saliva and nasopharyngeal swab samples for disease severity prediction

References

• Weekly epidemiological update on COVID-19 - 6 Apr 2023 [Internet]. [updated 2023 Apr 7]. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—6-april-2023
   Google Scholar
• Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020 Jun 25;58(7):1070–12. DOI:10.1515/cclm-2020-0285.
   PubMed Web of Science ®Google Scholar
• Khiabani K, Amirzade-Iranaq MH. Are saliva and deep throat sputum as reliable as common respiratory specimens for SARS-CoV-2 detection? A systematic review and meta-analysis. Am J Infect Control. 2021 Sep;49(9):1165–1176. doi:10.1016/j.ajic.2021.03.008.
   PubMed Web of Science ®Google Scholar
• Harding H, Broom A, Broom J. Aerosol-generating procedures and infective risk to healthcare workers from SARS-CoV-2: the limits of the evidence. J Hosp Infect. 2020 Aug;105(4):717–725. doi:10.1016/j.jhin.2020.05.037.
   PubMed Web of Science ®Google Scholar
• Karligkiotis A, Arosio A, Castelnuovo P. How to obtain a nasopharyngeal Swab Specimen. N Engl J Med. 2020 Jul 16;383(3):e14. DOI:10.1056/NEJMc2015949.
   PubMedGoogle Scholar
• Bruxvoort K, Tenggardjaja CF, Slezak J, et al. Variation in SARS-CoV-2 molecular test sensitivity by specimen types in a large sample of emergency department patients. Am J Emerg Med. 2021 Dec 1;50:381–387. DOI:10.1016/j.ajem.2021.08.034.
   PubMed Web of Science ®Google Scholar
• LeGoff J, Kernéis S, Elie C, et al. Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care. Sci Rep. 2021 Oct 26;11(1):21126. DOI:10.1038/s41598-021-00560-8.
   PubMed Web of Science ®Google Scholar
• Uddin MKM, Shirin T, Hossain ME, et al. Diagnostic performance of self-collected saliva versus nasopharyngeal swab for the molecular detection of SARS-CoV-2 in the clinical setting. Microbiol Spectr. 0(0): e00468-21. 10.1128/Spectrum.00468-21.
   Google Scholar
• Williams E, Bond K, Zhang B, et al. Saliva as a noninvasive specimen for detection of SARS-CoV-2. J Clin Microbiol. 2020 Jul 23;58(8): e00776-20. DOI: 10.1128/JCM.00776-20.
   Web of Science ®Google Scholar
• Czumbel LM, Kiss S, Farkas N, et al. Saliva as a candidate for COVID-19 diagnostic testing: a meta-analysis. Front Med. 2020 Aug 4;7:465. DOI:10.3389/fmed.2020.00465.
   PubMed Web of Science ®Google Scholar
• Palikša S, Lopeta M, Belevičius J, et al. Saliva testing is a robust non-invasive method for SARS-CoV-2 RNA detection. Infect Drug Resist. 2021;14:2943–2951.
   PubMed Web of Science ®Google Scholar
• Tan SH, Allicock O, Armstrong-Hough M, et al. Saliva as a gold-standard sample for SARS-CoV-2 detection. Lancet Respir Med. 2021;9:562–564.
   PubMed Web of Science ®Google Scholar
• IDSA and AMP joint statement on the use of SARS-CoV-2 PCR cycle threshold (Ct) values for clinical decision-making [Internet]. [updated 2022 May 10]. Available from: https://www.idsociety.org/globalassets/idsa/public-health/covid-19/idsa-amp-statement.pdf.
   Google Scholar
• Yoon JG, Yoon J, Song JY, et al. Clinical significance of a high SARS-CoV-2 viral load in the saliva. J Korean Med Sci. 2020 May 20;35(20):e195. DOI:10.3346/jkms.2020.35.e195.
   PubMed Web of Science ®Google Scholar
• Shenoy S. SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: a systematic review. World J Crit Care Med. 2021 Jul 9;10(4):132–150. DOI:10.5492/wjccm.v10.i4.132.
   PubMedGoogle Scholar
• COVID-19 treatment guidelines [Internet]. [updated 2023 March 31]. Available from: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
   Google Scholar
• Leung ECM, Chow VCY, Lee MKP, et al. Deep throat saliva as an alternative diagnostic specimen type for the detection of SARS-CoV-2. J Med Virol. 2021 Jan;93(1):533–536. doi:10.1002/jmv.26258.
   PubMed Web of Science ®Google Scholar
• Wong SCY, Tse H, Siu HK, et al. Posterior oropharyngeal saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis off Publ Infect Dis Soc Am. 2020 Jun 21 ciaa797;71:2939–2946. 10.1093/cid/ciaa797.
   PubMed Web of Science ®Google Scholar
• Azzi L, Carcano G, Gianfagna F, et al. Saliva is a reliable tool to detect SARS-CoV-2. J Infect. 2020 Jul;81(1):e45–50. doi:10.1016/j.jinf.2020.04.005.
   PubMed Web of Science ®Google Scholar
• Aydin S, Benk IG, Geckil AA. May viral load detected in saliva in the early stages of infection be a prognostic indicator in COVID-19 patients? J Virol Methods. 2021 Aug;294:114198. DOI:10.1016/j.jviromet.2021.114198.
   PubMed Web of Science ®Google Scholar
• Nagura-Ikeda M, Imai K, Tabata S, et al. Clinical evaluation of self-collected saliva by quantitative reverse transcription-PCR (RT-qPCR), direct RT-qPCR, reverse transcription-loop-mediated isothermal amplification, and a rapid antigen test to diagnose COVID-19. J Clin Microbiol. 2020 Aug 24;58(9). 10.1128/JCM.01438-20 e01438-20.
   PubMed Web of Science ®Google Scholar
• Ibrahimi N, Delaunay-Moisan A, Hill C, et al. Screening for SARS-CoV-2 by RT-PCR: saliva or nasopharyngeal swab? Rapid review and meta-analysis. PLoS ONE. 2021;16(6):e0253007.
   PubMed Web of Science ®Google Scholar
• Salto-Alejandre S, Berastegui-Cabrera J, Camacho-Martínez P, et al. SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome. Sci Rep. 2021 Jun 21;11(1):12931. DOI:10.1038/s41598-021-92400-y.
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Raftopoulos V, Vorou R, et al. Association between upper respiratory tract viral load, comorbidities, disease severity, and outcome of patients with SARS-CoV-2 infection. J Infect Dis. 2021 Apr 8;223(7):1132–1138. DOI:10.1093/infdis/jiaa804.
   PubMed Web of Science ®Google Scholar
• Argyropoulos KV, Serrano A, Hu J, et al. Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with outcome and symptoms. Am J Pathol. 2020 Sep;190(9):1881–1887. doi:10.1016/j.ajpath.2020.07.001.
   PubMed Web of Science ®Google Scholar
• Lee S, Kim T, Lee E, et al. Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea. JAMA Intern Med. 2020 Nov 1;180(11):1447–1452. DOI:10.1001/jamainternmed.2020.3862.
   PubMed Web of Science ®Google Scholar
• Zheng S, Fan J, Yu F, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020 Apr 21;369:m1443.
   PubMed Web of Science ®Google Scholar
• Rao SN, Manissero D, Steele VR, et al. A systematic review of the clinical utility of cycle threshold values in the context of COVID-19. Infect Dis Ther. 2020 Sep;9(3):573–586. doi:10.1007/s40121-020-00324-3.
   PubMed Web of Science ®Google Scholar
• Sarkar B, Sinha RN, Sarkar K. Initial viral load of a COVID-19-infected case indicated by its cycle threshold value of polymerase Chain Reaction could be used as a predictor of its transmissibility - an experience from Gujarat, India. Indian J Community Med off Publ Indian Assoc Prev Soc Med. 2020 Sep;45(3):278–282. doi:10.4103/ijcm.IJCM_593_20.
   PubMed Web of Science ®Google Scholar
• Liu L, Wei Q, Alvarez X, et al. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J Virol. 2011 Apr;85(8):4025–4030. doi:10.1128/JVI.02292-10.
   PubMed Web of Science ®Google Scholar
• Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCov on the epithelial cells of oral mucosa. Int J Oral Sci. 2020 Feb 24;12(1):1–5. DOI:10.1038/s41368-020-0074-x.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Serrano DA, Roy-Vallejo E, Zurita Cruz ND, et al. Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients. Sci Rep. 2021 Jun 23;11(1):13134. DOI:10.1038/s41598-021-92497-1.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhao B, Qu Y, et al. Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically Ill patients with coronavirus disease 2019. Clin Infect Dis off Publ Infect Dis Soc Am. 2020 Nov 5;71(8):1937–1942. DOI:10.1093/cid/ciaa449.
   PubMed Web of Science ®Google Scholar
• Xia XY, Wu J, Liu HL, et al. Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19. J Clin Virol off Publ Pan Am Soc Clin Virol. 2020 Jun;127:104360. DOI:10.1016/j.jcv.2020.104360.
   Web of Science ®Google Scholar
• Liu Y, Liao W, Wan L, et al. Correlation between relative nasopharyngeal virus RNA load and lymphocyte count disease severity in patients with COVID-19. Viral Immunol. 2021 Jun;34(5):330–335. doi:10.1089/vim.2020.0062.
   PubMed Web of Science ®Google Scholar
• Chua GT, Wong JSC, KKW T, et al. Saliva viral load better correlates with clinical and immunological profiles in children with coronavirus disease 2019. Emerg Microbes Infect. 2021 Dec;10(1):235–241. doi:10.1080/22221751.2021.1878937.
   PubMed Web of Science ®Google Scholar